BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19274523)

  • 1. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
    Higaki S; Watanabe K; Itahashi M; Shimomura Y
    Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
    Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
    Gebhardt BM; Kaufman HE; Hill JM
    Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylsalicylic acid reduces viral shedding induced by thermal stress.
    Gebhardt BM; Varnell ED; Kaufman HE
    Curr Eye Res; 2004; 29(2-3):119-25. PubMed ID: 15512958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model.
    Bhattacharjee PS; Neumann DM; Stark D; Thompson HW; Hill JM
    Curr Eye Res; 2006 Sep; 31(9):703-8. PubMed ID: 16966142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice.
    Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits.
    O'Brien WJ; Tsao LS; Taylor JL
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1847-53. PubMed ID: 9727407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
    Waterbury LD; Silliman D; Jolas T
    Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.
    Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion.
    Higaki S; Gebhardt BM; Lukiw WJ; Thompson HW; Hill JM
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1862-9. PubMed ID: 12036991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
    Noisakran SJ; Carr DJ
    Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A replication competent HSV-1(McKrae) with a mutation in the amino-terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea infection.
    Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
    Curr Eye Res; 2014 Jun; 39(6):596-603. PubMed ID: 24401006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The survival of herpes simplex virus in preserved murine corneas.
    Robert PY; Ducher V; Pleyer U; Denis F; Adenis JP; Ranger-Rogez S
    Ophthalmic Res; 2008 Oct; 40(6):329-32. PubMed ID: 18698148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of herpes virus on the ocular surface and suppression of its reactivation.
    Shimomura Y; Higaki S
    Cornea; 2011 Oct; 30 Suppl 1():S3-7. PubMed ID: 21912227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
    Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR assessment of HSV-1 corneal infection in animals treated with rose bengal and lissamine green B.
    Stroop WG; Chen TM; Chodosh J; Kienzle TE; Stroop JL; Ling JY; Miles DA
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2096-102. PubMed ID: 10892849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis in the HSV-1 latently infected mouse trigeminal ganglion.
    Higaki S; Deai T; Fukuda M; Shimomura Y
    Cornea; 2004 Nov; 23(8 Suppl):S42-7. PubMed ID: 15448479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation.
    Gebhardt BM; Varnell ED; Kaufman HE
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):114-20. PubMed ID: 15857277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular HSV-1 latency, reactivation and recurrent disease.
    Toma HS; Murina AT; Areaux RG; Neumann DM; Bhattacharjee PS; Foster TP; Kaufman HE; Hill JM
    Semin Ophthalmol; 2008; 23(4):249-73. PubMed ID: 18584563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.